Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
about
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveRole of DNA methylation in renal cell carcinomaIdentification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panelRationales for expression and altered expression of apoptotic protease activating factor-1 gene in gastric cancer.CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.Epigenetics of kidney cancer and bladder cancer.DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.The prognostic significance of DAPK1 in bladder cancer.5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma.Manipulating the epigenome for the treatment of urological malignancies.Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer.Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas.Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeuticsEpigenetic regulation of cell life and death decisions and deregulation in cancer.Hypomethylating agents for urologic cancers.Global epigenetic profiling in bladder cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.The epigenetics of renal cell tumors: from biology to biomarkers.Evaluating DAPK as a therapeutic target.DNA methylation and apoptosis resistance in cancer cellsThe Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.The epigenetic landscape of renal cancer.Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.Dioscin induces demethylation of DAPK-1 and RASSF-1alpha genes via the antioxidant capacity, resulting in apoptosis of bladder cancer T24 cells.Incorporating DNA Methyltransferase Inhibitors (DNMTis) in the Treatment of Genitourinary Malignancies: A Systematic Review.Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.Methylation of the APAF-1 and DAPK-1 promoter region correlates with progression of renal cell carcinoma in North Indian population.Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.Up-regulated miR-221 expression as a molecular diagnostic marker in laryngeal squamous cell carcinoma and its correlation with Apaf-1 expression.Evaluation of the prognostic and physiological functions of death associated protein kinase 1 in breast cancer.Targeting DNA Methyltranferases in Urological Tumors.Epigenetic Mechanisms in Cancer Formation and Progression
P2860
Q26744089-902FA4FF-8CEE-43CD-B199-EFFD3B5F20F5Q26801268-CED85EC2-00E9-4811-B96D-B0D6C34D31E7Q32174136-FD277B29-EF21-42E2-BC4B-7701DA8322DFQ35615797-63A492E9-86E0-47E0-BC11-865DAF1D88A9Q35857620-A928692A-6E26-4DAA-94B9-8CAFEFD43D00Q35857807-9B669FC8-BC06-4A6A-9E44-5EBC72C5A780Q36209868-B14898DB-C778-4A38-B160-C7C360E69E12Q36294164-AE070157-D0C3-4D7B-8E20-77FDE47908EDQ36339910-0CD512DB-E8BF-46FC-9D8B-EF0C5066FBFCQ36734447-EFCAED6A-94F7-48B4-8D4F-535DE7E7C348Q37093519-93B0599D-63E5-47E2-A706-D4D60906F639Q37524412-DBAD4512-3A85-478D-823A-4B63E25E21A4Q37624861-D07740CB-EBD0-4930-9B7C-AF993412E8BDQ37708916-FC3E4D6F-1725-45E1-B76D-3DDD77AA4225Q37785109-99608262-ED7A-4BC5-9DF2-77C96C736DC7Q37785993-8161C548-6209-4E7F-A864-C21606C695EBQ37854737-0DF8E283-CB82-4E10-A6E8-0945037767F5Q37962571-1EA21573-77CE-4E18-A116-5B380393DDBFQ37978544-DFACDC90-D965-4CC6-89D2-05A4BEB986F8Q38016153-11BBD4BD-AC4B-4589-9FE2-9FF43C78D188Q38168688-2AEAEBD5-1557-4A63-87A1-92285F4A8518Q38202821-F3F8E76B-29D5-4537-9CB9-AB3FCB44D692Q38448187-CC9232BD-A425-4CBC-8396-038EBEF4B0B1Q39021700-06994A34-123C-463A-AFDB-6626780D2D98Q39281830-2DD3E66B-BD2E-40F0-A8E0-D9A2031E47D7Q42292918-97164FAC-95E6-454D-AB93-FCC5D4E98B50Q48136845-7CCAC6E8-FC3D-4F57-A45F-8A04CB246570Q49744869-6EFAC57A-5737-4987-8171-8F8D09C2A040Q51413061-0295CC01-6708-4C17-B758-69D6DB06338EQ51793176-26CB078B-6716-4E39-A2AC-0A80D49B7DACQ52609425-62714A6E-4EE1-4CDA-85A4-642180C51914Q53325669-608A7AD0-41D5-44A4-B79F-ADD0EA805AFDQ54978013-2F093FEF-5B5E-4276-976A-AF89AF1F4685Q55435258-7A69F59F-B4F7-4B0B-A4C7-0C88F57C1410Q57570317-EB511798-D24C-46A7-A07A-47265A34B228
P2860
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Methylation of tumour suppress ...... in bladder and kidney cancer.
@ast
Methylation of tumour suppress ...... in bladder and kidney cancer.
@en
type
label
Methylation of tumour suppress ...... in bladder and kidney cancer.
@ast
Methylation of tumour suppress ...... in bladder and kidney cancer.
@en
prefLabel
Methylation of tumour suppress ...... in bladder and kidney cancer.
@ast
Methylation of tumour suppress ...... in bladder and kidney cancer.
@en
P2093
P2860
P356
P1476
Methylation of tumour suppress ...... in bladder and kidney cancer.
@en
P2093
C Kempkensteffen
F Christoph
J Köllermann
M Schostak
M Schrader
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603482
P407
P577
2006-11-28T00:00:00Z